CorMedix Inc.CRMDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +4829.40% | +810.22% | +312.10% |
| Gross Profit Growth | +0.00% | +0.00% | +12683.29% | +764.30% | +257.28% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +388.52% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +357.07% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +4.13% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -18.18% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -31.82% |
| Weighted Average Shares Growth | +7.17% | +13.46% | +17.89% | +29.08% | +28.18% |
| Weighted Average Shares Diluted Growth | +7.17% | +19.95% | +24.81% | +46.56% | +52.69% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +20696.87% | +820.58% | +231.50% |
| Inventory Growth | +260.79% | +222.69% | +140.17% | +334.87% | +291.02% |
| Asset Growth | +44.83% | +119.90% | +337.55% | +867.78% | +595.14% |
| Book Value per Share Growth | +12.62% | +74.54% | +305.24% | +393.68% | +273.51% |
| Debt Growth | -22.56% | -24.52% | -26.77% | +26664.29% | +28702.76% |
| R&D Expense Growth | -24.56% | +281.21% | +275.23% | +601.07% | +398.05% |
| SG&A Expenses Growth | +15.35% | -5.85% | +6.30% | +174.85% | -337.62% |